Literature DB >> 19327587

Bone marrow failure syndromes: paroxysmal nocturnal hemoglobinuria.

Charles J Parker1.   

Abstract

This article discusses the etiology of paroxysmal nocturnal hemoglobinuria (PNH) and its relationship to marrow hyperplasia. The author posits that the defining clinical pathology of PNH (ie, complementmediated intravascular hemolysis) is an epiphenomenon that is a consequence of an orchestrated response (ie, natural selection of PIGA-mutant stem cells) to a specific type of bone marrow injury (ie, immune mediated). Management of PNH is discussed also.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19327587     DOI: 10.1016/j.hoc.2009.01.014

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  3 in total

Review 1.  Pesg PNH diagnosis, follow-up and treatment guidelines.

Authors:  Fahri Sahin; Olga Meltem Akay; Mesut Ayer; Mehmet Sinan Dal; Sehmus Ertop; Osman Ilhan; Volkan Karakus; Mehmet Ali Ozcan; Vildan Ozkocaman; Hayri Ozsan; Ozan Salim; Mahmut Tobu; Anil Tombak; Tulin Firatli Tuglular; Mehmet Yilmaz; Ali Unal; Mustafa Nuri Yenerel; Guray Saydam
Journal:  Am J Blood Res       Date:  2016-08-05

Review 2.  Rational therapeutic options for patients with myeloproliferative neoplasms.

Authors:  Ronald Hoffman
Journal:  Trans Am Clin Climatol Assoc       Date:  2011

3.  Comparison of High Sensitivity and Conventional Flow Cytometry for Diagnosing Overt Paroxysmal Nocturnal Hemoglobinuria and Detecting Minor Paroxysmal Nocturnal Hemoglobinuria Clones.

Authors:  Sang Hyuk Park; Joseph Jeong; Seon Ho Lee; Dong Won Yoo; Yunsuk Choi; Jae Cheol Jo; Ji Hun Lim
Journal:  Ann Lab Med       Date:  2019-03       Impact factor: 3.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.